RSS

Bioasis

Biopharmaceutical company, Bioasis, and Hong-Kong based biologics company, WuXi Biologics, have announced an initial strategic collaboration for the development and manufacture of xB3-001 — a candidate for the treatment of brain cancer. Read more

News